Leucine Rich Bio - UnlistedMart

S.No.	Date	Round Name	Amount	TTM Revenue	Investors & Facilitators
1.	Nov 15, 2024	Angel	₹50.0 Lakh	₹4.3 Cr	Angel: Ashwin, Snehal
2.	Sep 15, 2023	Seed	₹40.1 Lakh	₹1.3 Cr	Inst: Omphalos Ventures Angel: Meenakshi, Akash, Budgiri, Sai
3.	Sep 30, 2022	Angel	-	₹1.1 Cr	Angel: Nitesh
4.	Oct 10, 2019	Angel	₹50.0 Lakh	₹47.4 Lakh	Angel: Raghavendra
5.	Apr 5, 2018	Seed	₹99.9 Lakh	₹76.4 Lakh	Inst: Omphalos Ventures
6.	Oct 4, 2017	Seed	₹98.9 Lakh	₹74.5 Lakh	Inst: Omphalos Ventures

Detailed Income Statement

FY 24-25 (in Cr)

5.6

0.2

5.4

Other income

0.0

5.3

Cost of materials consumed

2.4

Purchases of stock-in-trade

0

Changes in inventories of finished goods, work-in-progress and stock-in-trade

0

Employee benefit expense

0.9

Finance costs

0

Total depreciation, depletion and amortisation expense

0.3

1.6

Total profit before prior period items, exceptional items, extraordinary items and tax

0.3

Exceptional items before tax

0

Total profit before extraordinary items and tax

0.3

Extraordinary items before tax

0

Total profit before tax

0.3

(0.0)

Total profit (loss) for period from continuing operations

0.4

Profit (loss) from discontinuing operations before tax

0

Tax expense of discontinuing operations

0

Total profit (loss) from discontinuing operation after tax

0

Total profit (loss) for period

0.4

Basic earning per equity share before extraordinary items

0.0

Diluted earnings per equity share before extraordinary items

0.0

Basic earning per equity share

0.0

Diluted earnings per equity share

0.0

Detailed Balance Sheet

FY 24-25 (in Cr)

2.8

0.9

1.9

0.4

1.4

2.8

1.5

1.4

0.1

Deferred tax assets (net)

0

Other non-current assets

0

1.2

Detailed Cash Flow Statement	FY 24-25 (in Cr)

Detailed Income Statement

FY 23-24 (in Cr)

1.6

0

1.6

Other income

0.1

2.2

Cost of materials consumed

0.4

Purchases of stock-in-trade

0

Changes in inventories of finished goods, work-in-progress and stock-in-trade

0

Employee benefit expense

0.4

Finance costs

0

Total depreciation, depletion and amortisation expense

0.2

1.2

Total profit before prior period items, exceptional items, extraordinary items and tax

(0.5)

Exceptional items before tax

0

Total profit before extraordinary items and tax

(0.5)

Extraordinary items before tax

0

Total profit before tax

(0.5)

(0.0)

Total profit (loss) for period from continuing operations

(0.5)

Profit (loss) from discontinuing operations before tax

0

Tax expense of discontinuing operations

0

Total profit (loss) from discontinuing operation after tax

0

Total profit (loss) for period

(0.5)

Basic earning per equity share before extraordinary items

(0.0)

Diluted earnings per equity share before extraordinary items

(0.0)

Basic earning per equity share

(0.0)

Diluted earnings per equity share

(0.0)

Detailed Balance Sheet

FY 23-24 (in Cr)

1.5

0.0

1.5

0.1

1.4

1.5

1.1

1.0

0.1

Deferred tax assets (net)

0

Other non-current assets

0

0.4

Detailed Cash Flow Statement	FY 23-24 (in Cr)

Detailed Income Statement

FY 22-23 (in Cr)

1.0

0

1.0

Other income

0.0

1.2

Cost of materials consumed

0.5

Purchases of stock-in-trade

0

Changes in inventories of finished goods, work-in-progress and stock-in-trade

0

Employee benefit expense

0.1

Finance costs

0

Total depreciation, depletion and amortisation expense

0.2

0.4

Total profit before prior period items, exceptional items, extraordinary items and tax

(0.2)

Exceptional items before tax

0

Total profit before extraordinary items and tax

(0.2)

Extraordinary items before tax

0

Total profit before tax

(0.2)

0.0

Total profit (loss) for period from continuing operations

(0.2)

Profit (loss) from discontinuing operations before tax

0

Tax expense of discontinuing operations

0

Total profit (loss) from discontinuing operation after tax

0

Total profit (loss) for period

(0.2)

Basic earning per equity share before extraordinary items

(0.0)

Diluted earnings per equity share before extraordinary items

(0.0)

Basic earning per equity share

(0.0)

Diluted earnings per equity share

(0.0)

Detailed Balance Sheet

FY 22-23 (in Cr)

1.2

0.2

1.0

0.1

0.9

1.2

1.0

0.9

0.0

Deferred tax assets (net)

0

Other non-current assets

0

0.3

Detailed Cash Flow Statement	FY 22-23 (in Cr)

Detailed Income Statement

FY 21-22 (in Cr)

1.2

0

1.2

Other income

0.1

1.2

Cost of materials consumed

0.5

Purchases of stock-in-trade

0

Changes in inventories of finished goods, work-in-progress and stock-in-trade

0

Employee benefit expense

0.2

Finance costs

0

Total depreciation, depletion and amortisation expense

0.2

0.3

Total profit before prior period items, exceptional items, extraordinary items and tax

(0.0)

Exceptional items before tax

0

Total profit before extraordinary items and tax

(0.0)

Extraordinary items before tax

0

Total profit before tax

(0.0)

Total profit (loss) for period from continuing operations

(0.0)

Profit (loss) from discontinuing operations before tax

0

Tax expense of discontinuing operations

0

Total profit (loss) from discontinuing operation after tax

0

Total profit (loss) for period

(0.0)

Basic earning per equity share before extraordinary items

(0.0)

Diluted earnings per equity share before extraordinary items

(0.0)

Basic earning per equity share

(0.0)

Diluted earnings per equity share

(0.0)

Detailed Balance Sheet

FY 21-22 (in Cr)

1.4

0.3

1.1

0.1

0.9

1.4

1.0

0.0

Deferred tax assets (net)

0

Other non-current assets

0

0.4

Detailed Cash Flow Statement	FY 21-22 (in Cr)

Detailed Income Statement

FY 20-21 (in Cr)

0.5

0

0.5

Other income

0.0

0.8

Cost of materials consumed

0

Purchases of stock-in-trade

0

Changes in inventories of finished goods, work-in-progress and stock-in-trade

0

Employee benefit expense

0.1

Finance costs

0

Total depreciation, depletion and amortisation expense

0.2

0.4

Total profit before prior period items, exceptional items, extraordinary items and tax

(0.3)

Exceptional items before tax

0

Total profit before extraordinary items and tax

(0.3)

Extraordinary items before tax

0

Total profit before tax

(0.3)

0.0

Total profit (loss) for period from continuing operations

(0.3)

Profit (loss) from discontinuing operations before tax

0

Tax expense of discontinuing operations

0

Total profit (loss) from discontinuing operation after tax

0

Profit (loss) of minority interest

0

Share of profit (loss) of associates

0

Total profit (loss) for period

(0.3)

Basic earning per equity share before extraordinary items

(0.0)

Diluted earnings per equity share before extraordinary items

(0.0)

Basic earning per equity share

(0.0)

Diluted earnings per equity share

(0.0)

Detailed Balance Sheet

FY 20-21 (in Cr)

1.3

0.3

1.0

0.1

0.9

1.3

1.0

0

Deferred tax assets (net)

0

Other non-current assets

0

0.3

Detailed Cash Flow Statement	FY 20-21 (in Cr)

Detailed Income Statement

FY 19-20 (in Cr)

0.4

0

0.4

Other income

0.1

0.9

Cost of materials consumed

0

Purchases of stock-in-trade

0

Changes in inventories of finished goods, work-in-progress and stock-in-trade

0

Employee benefit expense

0.1

Finance costs

0

Total depreciation, depletion and amortisation expense

0.2

0.6

Total profit before prior period items, exceptional items, extraordinary items and tax

(0.4)

Exceptional items before tax

0

Total profit before extraordinary items and tax

(0.4)

Extraordinary items before tax

0

Total profit before tax

(0.4)

0.0

Total profit (loss) for period from continuing operations

(0.5)

Profit (loss) from discontinuing operations before tax

0

Tax expense of discontinuing operations

0

Total profit (loss) from discontinuing operation after tax

0

Total profit (loss) for period

(0.5)

Basic earning per equity share before extraordinary items

(0.0)

Diluted earnings per equity share before extraordinary items

(0.0)

Basic earning per equity share

(0.0)

Diluted earnings per equity share

(0.0)

Detailed Balance Sheet

FY 19-20 (in Cr)

1.3

0.6

0.1

0.6

1.3

1.1

0.0

Deferred tax assets (net)

0

Other non-current assets

0

0.2

Detailed Cash Flow Statement	FY 19-20 (in Cr)

Detailed Income Statement

FY 18-19 (in Cr)

0.5

0

0.5

Other income

0.0

1.5

Cost of materials consumed

0

Purchases of stock-in-trade

0

Changes in inventories of finished goods, work-in-progress and stock-in-trade

0

Employee benefit expense

0.6

Finance costs

0

Total depreciation, depletion and amortisation expense

0.0

0.8

Total profit before prior period items, exceptional items, extraordinary items and tax

(0.9)

Exceptional items before tax

0

Total profit before extraordinary items and tax

(0.9)

Extraordinary items before tax

0

Total profit before tax

(0.9)

0.0

Total profit (loss) for period from continuing operations

(0.9)

Profit (loss) from discontinuing operations before tax

0

Tax expense of discontinuing operations

0

Total profit (loss) from discontinuing operation after tax

0

Total profit (loss) for period

(0.9)

Basic earning per equity share before extraordinary items

(0.0)

Diluted earnings per equity share before extraordinary items

(0.0)

Basic earning per equity share

(0.0)

Diluted earnings per equity share

(0.0)

Detailed Balance Sheet

FY 18-19 (in Cr)

1.3

0.6

0.7

0.1

0.6

1.3

1.1

1.0

0.1

Deferred tax assets (net)

0

Other non-current assets

0

0.2

Detailed Cash Flow Statement	FY 18-19 (in Cr)

Detailed Income Statement

FY 17-18 (in Cr)

0.8

0.3

0

0.3

Other income

0.4

0.9

Cost of materials consumed

0

Purchases of stock-in-trade

0

Changes in inventories of finished goods, work-in-progress and stock-in-trade

0

Employee benefit expense

0.2

Finance costs

0

Total depreciation, depletion and amortisation expense

0.0

0.5

Total profit before prior period items, exceptional items, extraordinary items and tax

(0.1)

Exceptional items before tax

0

Total profit before extraordinary items and tax

(0.1)

Extraordinary items before tax

0

Total profit before tax

(0.1)

0.0

Total profit (loss) for period from continuing operations

(0.2)

Profit (loss) from discontinuing operations before tax

0

Tax expense of discontinuing operations

0

Total profit (loss) from discontinuing operation after tax

0

Total profit (loss) for period

(0.2)

Basic earning per equity share before extraordinary items

(0.0)

Diluted earnings per equity share before extraordinary items

(0.0)

Basic earning per equity share

(0.0)

Diluted earnings per equity share

(0.0)

Detailed Balance Sheet

FY 17-18 (in Cr)

0.8

0.6

0.2

0.1

0.8

0.7

0.6

0.1

Deferred tax assets (net)

0

Other non-current assets

0

0.1

Detailed Cash Flow Statement	FY 17-18 (in Cr)

Detailed Income Statement

FY 16-17 (in Cr)

0.7

0.1

0

0.1

Other income

0.6

Cost of materials consumed

0

Purchases of stock-in-trade

0

Changes in inventories of finished goods, work-in-progress and stock-in-trade

0

Employee benefit expense

0.3

Finance costs

0

Total depreciation, depletion and amortisation expense

0.0

0.2

Total profit before prior period items, exceptional items, extraordinary items and tax

0.1

Exceptional items before tax

0

Total profit before extraordinary items and tax

0.1

Extraordinary items before tax

0

Total profit before tax

0.1

0.0

Total profit (loss) for period from continuing operations

0.1

Profit (loss) from discontinuing operations before tax

0

Tax expense of discontinuing operations

0

Total profit (loss) from discontinuing operation after tax

0

Total profit (loss) for period

0.1

Basic earning per equity share before extraordinary items

0.0

Diluted earnings per equity share before extraordinary items

0

Basic earning per equity share

0.0

Diluted earnings per equity share

0

Detailed Balance Sheet

FY 16-17 (in Cr)

0.1

(0.3)

0.4

0.0

0.4

0.1

0.0

Deferred tax assets (net)

0

Other non-current assets

0

0.0

Detailed Cash Flow Statement	FY 16-17 (in Cr)

Detailed Income Statement

FY 15-16 (in Cr)

0.1

0

0.1

Other income

0

0.3

Cost of materials consumed

0

Purchases of stock-in-trade

0

Changes in inventories of finished goods, work-in-progress and stock-in-trade

0

Employee benefit expense

0.2

Finance costs

0

Total depreciation, depletion and amortisation expense

0.0

0.1

Total profit before prior period items, exceptional items, extraordinary items and tax

(0.3)

Exceptional items before tax

0

Total profit before extraordinary items and tax

(0.3)

Extraordinary items before tax

0

Total profit before tax

(0.3)

0.0

Total profit (loss) for period from continuing operations

(0.3)

Profit (loss) from discontinuing operations before tax

0

Tax expense of discontinuing operations

0

Total profit (loss) from discontinuing operation after tax

0

Total profit (loss) for period

(0.3)

Basic earning per equity share before extraordinary items

(0.0)

Diluted earnings per equity share before extraordinary items

(0.0)

Basic earning per equity share

(0.0)

Diluted earnings per equity share

(0.0)

Detailed Balance Sheet

FY 15-16 (in Cr)

0.1

(0.4)

0.5

0.0

0.4

0.1

0.0

Deferred tax assets (net)

0

Other non-current assets

0

0.0

Detailed Cash Flow Statement	FY 15-16 (in Cr)

Detailed Income Statement

FY 14-15 (in Cr)

0.0

0.1

Profit before exceptional and extraordinary items and tax

(0.1)

Profit before extraordinary items and tax

(0.1)

Profit before tax

(0.1)

0.0

Profit (Loss) for the period from continuing Operations

(0.1)

Profit/ (Loss)

(0.1)

EPS - Basic

(0.0)

EPS - Diluted

(0.0)

Detailed Balance Sheet

FY 14-15 (in Cr)

0.0

(0.1)

0.1

0.0

Detailed Cash Flow Statement	FY 14-15 (in Cr)

Shareholder	Category	Shares (Mn)	% Holding
Kumar Sankaran	Founder	0.00M	26.21%
Prabhath Kamath	Founder	0.00M	26.21%
Omphalos Ventures India LLP	Fund	0.00M	19.39%
Debojyoti Dhar	Founder	0.00M	13.10%
ESOP Pool Available	ESOP Pool	0.00M	7.39%

Key Metrics of Leucine Rich Bio

Funding Rounds

Total Rounds: 6 Leucinerichbio

Financial Statements

Revenue - INR (Cr)

Net Profit/Loss - INR (Cr)

Select a year from the tabs

Shareholding Pattern

Top Shareholders

Others

Top Competitors

Deep Genomics

Hexagon Bio

MaaT Pharma

Synlogic Therapeutics

Kallyope

BC Platforms